Hamill John P. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$8,660.59
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Hamill John P.

According to the SEC Form 4 filings, Hamill John P., being in a position of

  1. SrVP/CFO/Prin Fin & Acct Ofcr at Aprea Therapeutics, Inc.,
    оver the last 12 months, has bought 10700 shares for $10,898, and sold 0 shares,
    over all time since 2024-03-13, has bought 12210 shares for $19,559, and sold 0 shares.

Biography of Hamill John P.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $10,8982100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-01-30PurchaseAprea Therapeutics, Inc.
APRE
SrVP/CFO/Prin Fin & Acct Ofcr
5,700
0.0911%
$0.89$5,073-5.78%
2025-12-10PurchaseAprea Therapeutics, Inc.
APRE
SrVP/CFO/Prin Fin & Acct Ofcr
5,000
0.1043%
$1.17$5,825-16.14%
2024-10-11PurchaseAprea Therapeutics, Inc.
APRE
SrVP/CFO/Prin Fin & Acct Ofcr
50
0.0008%
$2.46$123-28.08%
2024-10-10PurchaseAprea Therapeutics, Inc.
APRE
SrVP/CFO/Prin Fin & Acct Ofcr
450
0.0074%
$2.61$1,175-26.18%
2024-03-13PurchaseAprea Therapeutics, Inc.
APRE
SrVP/CFO/Prin Fin & Acct Ofcr
1,010
0.0345%
$7.29$7,363-31.44%
Total: 5
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.